Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Novateor Research LaboratoriesBOM:542771 59 EBITDA Margin % is 18.51% as of Mar. 2026, which is 16% below its 10-year median of 21.97. GuruFocus rates BOM:542771 with a GF Score™ of 59/100 and a GF Value™ of ₹83.64. The stock has 2 warning signs investors should review. Among 1,957 Consumer Packaged Goods companies, Novateor Research Laboratories ranks better than 54.62% on this metric.
Novateor Research Laboratories (BOM:542771) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Novateor Research Laboratories EBITDA Margin % Related Terms
Novateor Research Laboratories EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novateor Research Laboratories EBITDA Margin % Chart
BOM:542771 vs PG, CL, KVUE: EBITDA Margin % Comparison
For the Household & Personal Products subindustry, Novateor Research Laboratories's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novateor Research Laboratories EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Novateor Research Laboratories's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Novateor Research Laboratories's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novateor Research Laboratories (BOM:542771) has a EBITDA Margin % of 18.51% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Novateor Research Laboratories and its competitors. This is 16% below median its historical median of 21.97. According to the industry distribution chart, Novateor Research Laboratories ranks #888 out of 1957 companies in the Consumer Packaged Goods industry, placing it in the top 45.4%.
Is Novateor Research Laboratories' EBITDA Margin % too high?
Novateor Research Laboratories' current EBITDA Margin % of 18.51% is 16% below median its 10-year median of 21.97. The Consumer Packaged Goods industry median EBITDA Margin % is 9.00. Novateor Research Laboratories' value of 18.51% is 105.7% above this industry median. Based on the distribution chart, Novateor Research Laboratories ranks #888 out of 1957 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Novateor Research Laboratories has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Novateor Research Laboratories' EBITDA Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Novateor Research Laboratories ranks #888 out of 1957 companies for EBITDA Margin %. This puts Novateor Research Laboratories in the upper half of its industry. The industry median EBITDA Margin % is 9.00. Novateor Research Laboratories' value of 18.51% is 105.7% above this benchmark. While the company's 10-year median is 21.97 vs. the industry median of 9.00, Novateor Research Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 9.00, based on 1,957 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novateor Research Laboratories's current EBITDA Margin % of 18.51% is 105.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Novateor Research Laboratories and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 9.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novateor Research Laboratories's current EBITDA Margin % is 18.51%, which is 16% below median its own 10-year median of 21.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novateor Research Laboratories stock overvalued right now?
Novateor Research Laboratories (BOM:542771) has a current EBITDA Margin % of 18.51%. The stock's GF Value™ is ₹83.64, compared to a current price of ₹32.85 — trading 60.7% below its estimated fair value. The current EBITDA Margin % is 18.51%, which is 16% below median its 10-year median of 21.97 and 105.7% above the Consumer Packaged Goods industry median of 9.00. Novateor Research Laboratories' overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Novateor Research Laboratories (BOM:542771), the current EBITDA Margin % is 18.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novateor Research Laboratories (BOM:542771) Overvalued in 2026?
Based on GuruFocus' analysis, Novateor Research Laboratories stock appears to be undervalued.
The current stock price of ₹32.85 is trading 60.7% below its estimated GF Value™ of ₹83.64.
Key valuation signals for BOM:542771:
EBITDA Margin %: 18.51% (16% below median its 10-year median of 21.97)
GF Value™: ₹83.64 vs. price of ₹32.85 (60.7% below fair value)
Industry Position: 105.7% above the Consumer Packaged Goods median (#888 of 1957)
No single metric tells the full story. See the BOM:542771 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novateor Research Laboratories Ltd is a company engaged in the development of novel personal care products that are intended to provide safe, easy, and innovative approaches to the existing traditional personal care solutions. The company's teeth-whitening products are sold under the brand name SmiloShine. The company manufactures three different variants of teeth whitening strips, teeth whitening toothpaste and brush, kids's toothpaste and tongue cleaner, and teeth whitening gel.
59GF Score
Get the complete analysis for BOM:542771
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542771 has been successfully added to your 
